363 related articles for article (PubMed ID: 29658564)
1. C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.
Shi H; Mao Y; Ju Q; Wu Y; Bai W; Wang P; Zhang Y; Jiang M
Int J Oncol; 2018 Jul; 53(1):167-176. PubMed ID: 29658564
[TBL] [Abstract][Full Text] [Related]
2. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16INK4A.
Guan C; Shi H; Wang H; Zhang J; Ni W; Chen B; Hou S; Yang X; Shen A; Ni R
J Cell Biochem; 2013 Jun; 114(6):1343-54. PubMed ID: 23255392
[TBL] [Abstract][Full Text] [Related]
3. CtBP2 interacts with TGIF to promote the progression of esophageal squamous cell cancer through the Wnt/β‑catenin pathway.
Ju Q; Jiang M; Huang W; Yang Q; Luo Z; Shi H
Oncol Rep; 2022 Feb; 47(2):. PubMed ID: 34878149
[TBL] [Abstract][Full Text] [Related]
4. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
Liu L; Ju Y; Wang J; Zhou R
Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
[TBL] [Abstract][Full Text] [Related]
5. RUNX3 reverses cisplatin resistance in esophageal squamous cell carcinoma via suppression of the protein kinase B pathway.
Li DJ; Shi M; Wang Z
Thorac Cancer; 2016 Sep; 7(5):570-580. PubMed ID: 27766776
[TBL] [Abstract][Full Text] [Related]
6. Interaction with CCNH/CDK7 facilitates CtBP2 promoting esophageal squamous cell carcinoma (ESCC) metastasis via upregulating epithelial-mesenchymal transition (EMT) progression.
Zhang J; Zhu J; Yang L; Guan C; Ni R; Wang Y; Ji L; Tian Y
Tumour Biol; 2015 Sep; 36(9):6701-14. PubMed ID: 25820824
[TBL] [Abstract][Full Text] [Related]
7. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA LINC00337 induces autophagy and chemoresistance to cisplatin in esophageal squamous cell carcinoma cells via upregulation of TPX2 by recruiting E2F4.
Yang C; Shen S; Zheng X; Ye K; Ge H; Sun Y; Lu Y
FASEB J; 2020 May; 34(5):6055-6069. PubMed ID: 32239565
[TBL] [Abstract][Full Text] [Related]
9. High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.
Chen L; Ni S; Li M; Shen C; Lin Z; Ouyang Y; Xia F; Liang L; Jiang W; Ni R; Zhang J
Dig Dis Sci; 2017 Feb; 62(2):387-395. PubMed ID: 27995408
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NEAT1 Regulates Cell Viability and Invasion in Esophageal Squamous Cell Carcinoma through the miR-129/CTBP2 Axis.
Li Y; Chen D; Gao X; Li X; Shi G
Dis Markers; 2017; 2017():5314649. PubMed ID: 29147064
[TBL] [Abstract][Full Text] [Related]
11. Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line.
Qiu Y; Zou YB; Li K; Jiang YG; Yang K; Zhao YP; Guo W
Curr Cancer Drug Targets; 2012 Oct; 12(8):950-61. PubMed ID: 22794122
[TBL] [Abstract][Full Text] [Related]
12.
Hou XF; Xu LP; Song HY; Li S; Wu C; Wang JF
World J Gastroenterol; 2017 Mar; 23(10):1796-1803. PubMed ID: 28348485
[TBL] [Abstract][Full Text] [Related]
13. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
Wang S; Akhtar J; Wang Z
Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168
[TBL] [Abstract][Full Text] [Related]
14. miR-203a-3p regulates the cellular processes of esophageal cancer cells via targeting CtBP2.
Jiang M; Shi H; Xu Y; Bai W; Wang P; Ju Q
Transl Cancer Res; 2019 Dec; 8(8):2791-2802. PubMed ID: 35117036
[TBL] [Abstract][Full Text] [Related]
15. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.
Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH
World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of autophagy regulating chemoresistance in esophageal cancer cells.
Fang F; Li Y; Chang L
Exp Mol Pathol; 2020 Dec; 117():104564. PubMed ID: 33137292
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of RUNX3 inhibits malignant behaviour of Eca109 cells in vitro and vivo.
Chen HX; Wang S; Wang Z; Zhang ZP; Shi SS
Asian Pac J Cancer Prev; 2014; 15(4):1531-7. PubMed ID: 24641363
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 promotes the proliferation and inhibits apoptosis in Eca109 via activating ERK1/2/MAPK pathway.
Liu F; Zheng S; Liu T; Liu Q; Liang M; Li X; Sheyhidin I; Lu X; Liu W
Mol Cell Biochem; 2013 Sep; 381(1-2):115-25. PubMed ID: 23709326
[TBL] [Abstract][Full Text] [Related]
19. Effect of sinomenine hydrochloride on radiosensitivity of esophageal squamous cell carcinoma cells.
Fu S; Jin L; Gong T; Pan S; Zheng S; Zhang X; Yang T; Sun Y; Wang Y; Guo J; Hui B; Zhang X
Oncol Rep; 2018 Apr; 39(4):1601-1608. PubMed ID: 29393484
[TBL] [Abstract][Full Text] [Related]
20. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]